Cancer cells hijack tumor-associated macrophages to sustain their outgrowth. In this issue, Mougiakakos and colleagues identify the IKZF1–IRF4/IRF5 axis as a key molecular pathway regulating macrophage polarization in multiple myeloma. These results suggest targeting IKZF1 could provide a new strategy to reprogram myeloma-associated macrophages toward a tumoricidal and immune-activating phenotype.
CITATION STYLE
de Sanctis, F., & Bronte, V. (2021). How to reprogram myeloma-associated macrophages: Target IKZF1. Cancer Immunology Research, 9(3), 254. https://doi.org/10.1158/2326-6066.CIR-21-0026
Mendeley helps you to discover research relevant for your work.